{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Sanofi", "item": "https://www.patentleaderboard.com/2021/company/sanofi"}, {"@type": "ListItem", "position": 4, "name": "Nils Poth", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ni_ln:poth-1"}]}

Home › 2021 › Sanofi › Nils Poth

Nils Poth — 1 Patent in 2021

SASanofi: 1 patents #52 of 191Top 30%

Frankfurt am Main, DE: #79 of 220 inventorsTop 40%

Overall (2021): #316,270 of 548,734Top 60%

1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #	Title	Co-Inventors	Date	Approx Value ⓘ
11141489	Conjugates comprising an GLP-1/Glucagon dual agonist, a linker and hyaluronic acid	Dieter Kadereit, Michael Wagner, Thomas Olpp, Nino Meyer, Martin Bossart +5 more	2021-10-12	$18,446,000

Nils Poth — 1 Patent in 2021

Issued Patents 2021

Patent Widget